7222 Journal of Medicinal Chemistry, 2005, Vol. 48, No. 23
Gangjee et al.
(7) Kisliuk, R. L.; Gaumont, Y.; Powers, J. F.; Thorndike, J.; Nair,
M. G.; Piper, J. R. Synergistic Growth Inhibition by Combination
of Antifolates. In Evaluation of Folate Metabolism in Health and
Disease; Picciano, M. F., Stokstad, E. L. R., Gregory, J. F., III,
Eds.; Alan R. Liss: New York, 1990; pp 79-89.
(8) Galivan, J.; Nimec, Z.; Rhee, M. S. Synergistic Growth Inhibition
of Rat Hepatoma Cells Exposed in Vitro to N-10-Propargyl-5,8-
dideazafolate with Methotrexate or the Lipophilic Antifolates
Trimetrexate or Metoprine. Cancer Res. 1988, 47, 5256-5260.
(9) Galivan, J.; Rhee, M. S.; Johnson, T. B.; Dilwith, R.; Nair, M.
G.; Bunni, M.; Priest, D. G. The Role of Cellular Folates in the
Enhancement of Activity of the Thymidylate Synthase Inhibitor
10-Propargyl-5,8-dideazafolate against Hepatoma Cells in vitro
by Inhibitors of Dihydrofolate Reductase. J. Biol. Chem. 1989,
264, 10685-10692.
(10) Gaumont, Y.; Kisliuk, R. L.; Emkey, R.; Piper, J. R.; Nair, M.
G. Folate Enhancement of Antifolate Synergism in Human
Lymphoma Cells. In Chemistry and Biology of Pteridines;
Curtius, H. C., Blau, N., Ghisla, S., Eds.; W. deGruyter: Berlin,
1990; pp 1132-1136.
(11) Gaumont, Y.; Kisliuk, R. L.; Parsons, J. C.; Greco, W. R.
Quanatitation of Folic Acid Enhancement of Antifolate Syner-
gism. Cancer Res. 1992, 52, 2228-2235.
(24) Gangjee, A.; Lin, X.; McGuire, J. J.; Queener, S. F. Design and
Synthesis of N-[4-[(2,4-Diamino-5-methylpyrrolo[2,3-d]pyrimi-
din-6-yl)thio]benzoyl]-L-glutamic Acid as a Classical DHFR
Inhibitor. Abstracts of Papers, 223rd National Meeting of the
American Chemical Society, Orlando, FL, April 7-11, 2002;
MEDI-190.
(25) Taylor, E. C.; Patel, H. H.; Jun, J.-G. A One-Step Ring Trans-
formation/Ring Annulation Approach to Pyrrolo[2,3-d]pyrim-
idines. A New Synthesis of the Potent Dihydrofolate Reductase
Inhibitor TNP-351. J. Org. Chem. 1995, 60, 6684-6687.
(26) Gangjee, A.; Lin, X.; Queener, S. F. Design, Synthesis, and
Biological Evaluation of 2,4-Diamino-5-methyl-6-substituted-
pyrrolo[2,3-d]pyrimidines as Dihydrofolate Reductase Inhibitors.
J. Med. Chem. 2004, 47, 3689-3692.
(27) Sayre, P. H.; Finer-Moore, J. S.; Fitz, T. A.; Biermann, D.; Gates,
S. B.; MacKellar, W. C.; Patel, V. F.; Strout, R. M. Multi-targeted
Antifolates Aimed at Avoiding Drug Resistance Form Covalent
Closed Inhibitory Complexes with Human and Escherichia coli
Thymidylate Synthases. J. Mol. Biol. 2001, 313, 813-829.
(28) Foley, G. F.; Lazarus, H.; Farber, S.; Uzman, B. G.; Boone, B.
A.; McCarthy, R. E. Continuous Culture of Lymphoblasts from
Peripheral Blood of a Child with Acute Leukemia. Cancer 1965,
18, 522-529.
(29) McCloskey, D. E.; McGuire, J. J.; Russell, C. A.; Rowan, B. G.;
Bertino, J. R.; Pizzorno, G.; Mini, E. Decreased Folylpoly-
glutamate Synthetase Activity as a Mechanism of Methotrexate
Resistance in CCRF-CEM Human Leukemia Sublines. J. Biol.
Chem. 1991, 266, 6181-6187.
(12) Hynes, J. B.; Harmon, S. J.; Floyd, G. G.; Farrington, M.; Hart,
L. D.; Gale, G. R.; Washtein, W. L.; Sustern, S. S.; Freisheim, J.
H. Chemistry and Antitumor Evaluation of Selected Classical
2,4-Diaminoquinazoline Analogues of Folic Acid. J. Med. Chem.
1985, 28, 209-215.
(30) McGuire, J. J.; Magee, K. J.; Russell, C. A.; Canestrari, J. M.
Thymidylate Synthase as a Target for Growth Inhibition in
Methotrexate-Sensitive and -Resistant Human Head and Neck
Cancer and Leukemia Cell Lines. Oncol. Res. 1997, 9, 139-147.
(31) Mini, E.; Srimatkandada, S.; Medina, W. D.; Moroson, B. A.;
Carman, M. D.; Bertino, J. R. Molecular and Karyological
Analysis of Methotrexate-Resistant and -Sensitive Human
Leukemic CCRF-CEM Cells. Cancer Res. 1985, 45, 317-325.
(32) Rosowsky, A.; Lazarus, H.; Yuan, G. C.; Beltz, W. R.; Mangini,
L.; Abelson, H. T.; Modest, E. J.; Frei, E., III. Effects of
Methotrexate Esters and Other Lipophilic Antifolates on Meth-
otrexate-Resistant Human Leukemic Lymphoblasts. Biochem.
Pharmacol. 1980, 29, 648-652.
(33) Gangjee, A.; Yu, J.; Kisliuk, R. L.; Haile, W. H.; Sobrero, G.;
McGuire, J. J. Design, Synthesis, and Biological Activities of
Classical N-[4-[2-(2-amino-4-ethylpyrrolo[2,3-d]pyrimidin-5-yl)-
ethylpyrrolo[2,3-d]pyrimidin-5-yl]ethyl]benzoyl]-L-glutamic Acid
and Its 6-Methyl Derivative as Potential Dual Inhibitors of
Thymidylate Synthase and Dihydrofolate Reductase and as
Potential Antitumor Agents. J. Med. Chem. 2003, 46, 591-600.
(34) Hakala, M. T.; Taylor, E. The Ability of Purine and Thymidine
Derivatives and of Glycine To Support the Growth of Mam-
malian Cells in Culture. J. Biol. Chem. 1959, 234, 126-128.
(35) We thank the Developmental Therapeutics Program of the
National Cancer Institute for performing the in vitro anticancer
evaluation.
(36) Kisliuk, R. L.; Strumpf, D.; Gaumont, Y.; Leary, R. P.; Plante,
L. Diastereoisomers of 5,10-Methylene-5,6,7,8-tetrahydropteroyl-
D-glutamic Acid. J. Med. Chem. 1977, 20, 1531-1533.
(37) Wahba, A. J.; Friedkin, M. The Enzymatic Synthesis of Thymidy-
late. Early Step in the Purification of Thymidylate Synthetase
of Escherichia coli. J. Biol. Chem. 1962, 237, 3794-3801.
(38) Davisson, V. J.; Sirawaraporn, W.; Santi, D. V. Expression of
Human Thymidylate Synthase in Escherichia coli. J. Biol. Chem.
1989, 264, 9145-9148.
(39) Blakley, R. L. The Biochemistry of Folic Acid and Related
Pteridines; Elsevier: Amsterdam, 1969; p 569.
(40) Grindey, G. B.; Wang, M. C.; Kinahan, J. J. Thymidine Induced
Perturbations in Ribonucleoside and Deoxyribonucleoside Tri-
phosphate Pools in Human Leukemic CCRF-CEM Cells. Mol.
Pharmacol. 1979, 16, 601-606.
(13) Rosowsky, A. Chemistry and Biological Activity of Antifolates.
In Progress in Medicinal Chemistry; Ellis, G. P., West, G. B.,
Eds.; Elsevier Science: New York, 1989; Vol. 26, pp 1-252.
(14) Gangjee, A.; Elzein, E.; Kothare, M.; Vasudevan, A. Classical
and Nonclassical Antifolates as Potential Antitumor, Antipneu-
mocystis and Antitoxoplasma Agents. Curr. Pharm. Des. 1996,
2, 263-280.
(15) Gangjee, A.; Yu, J.; McGuire, J. J.; Cody, V.; Galitsky, N.;
Kisliuk, R. L.; Queener, S. F. Design, Synthesis, and X-ray
Crystal Structure of a Potent Dual Inhibitor of Thymidylate
Synthase and Dihydrofolate Reductase as an Antitumor Agent.
J. Med. Chem. 2000, 43, 3837-3851.
(16) Baugh, C. M.; Krumdieck, C. L.; Nair, M. G. Poly-γ-glutamyl
Metabolites of Methotrexate. Biochem. Biophys. Res. Commun.
1973, 52, 27-34.
(17) Pizzorno, G.; Mini, E.; Coronnello, M.; McGuire, J. J.; Moroson,
B. A.; Cashmore, A. R.; Dreyer, R. N.; Lin, J. T.; Mazzei, T.
Impaired Polyglutamylation of Methotrexate as a Cause of
Resistance in CCRF-CEM Cells after Short-Term, High-Dose
Treatment with this Drug. Cancer Res. 1988, 48, 2149-2155.
(18) McGuire, J. J.; Coward, J. K. In Folates and Pterins; Blakley,
R. L., Benkovic, S. J., Eds.; John Wiley & Sons: New York 1984;
Vol. 1, pp 135-190.
(19) Gangjee, A.; Devraj, R.; McGuire, J. J.; Kisliuk, R. L. 5-Arylthio
Substituted 2-Amino-4-oxo-6-methylpyrrolo[2,3-d]pyrimidine An-
tifolates as Thymidylate Synthase Inhibitors and Antitumor
Agents. J. Med. Chem. 1995, 38, 4495-4502.
(20) Marsham, P. R.; Jackman, A. L.; Barker, A. J.; Boyle, F. T.; Pegg,
S. J.; Wardleworth, J. M.; Kimbell, R.; O’Connor, B. M.; Calvert,
A. H.; Hughes, L. R. Quinazoline Antifolate Thymidylate Syn-
thase Inhibitors: Replacement of Glutamic Acid in the C2-
Methyl Series. J. Med. Chem. 1995, 38, 994-1004.
(21) Piper, J. R.; McCaleb, G. S.; Montgomery, J. A.; Kisliuk, R. L.;
Gaumont, Y.; Sirotnak, F. M. Synthesis and Antifolate Activity
of 5-Methyl-5-Deaza Analogs of Aminopterin, MTX, Folic Acid
and N10-Methyl Folic Acid. J. Med. Chem. 1986, 29, 1080-1087.
(22) Tripos Inc., 1699 South Hanley Road, St. Louis, MO, 63144.
(23) Gangjee, A.; Yang, J.; Queener, S. F. Design and Synthesis of
2,4-Diamino-5-methyl-6-arylmethyl Pyrrolo[2,3-d]pyrimidines as
DHFR Inhibitors. Abstracts of Papers, 222nd National Meeting
of the American Chemical Society, Chicago, IL, August 26-30,
2001; MEDI-070.
JM058234M